Category Archives: Transient Elastography and Fibroscan

Screening For Silent Liver Disease: “Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease” With An Additional Link

In addition to today’s article, please review Transient Elastography and Fibroscan: Stethoscope of a Hepatologist in Today’s World [PubMed Abstract] [Full-Text HTML] [Full-Text PDF]. Curr Hepatol Rep. 2025 Dec;24(1):10.1007/s11901-025-00713-7. doi: 10.1007/s11901-025-00713-7. Epub 2025 Nov 27. Abstract Purpose of review: Vibration-controlled transient … Continue reading

Posted in Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease, Screening For Silent Liver Disease, Transient Elastography and Fibroscan | Comments Off on Screening For Silent Liver Disease: “Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease” With An Additional Link